Prime Medicine PRME
NASDAQ PRME
$4.30 +0.40 (+10.26%)
At close: Nov 11, 2026 · 4:00 PM EST

Prime Medicine (PRME) Gains (Losses) on Sale of Assets & Investments (2022 - 2026)

Updated

Analysis

Prime Medicine (PRME) Gains (Losses) on Sale of Assets & Investments (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Prime Medicine 704.88 Mn 469.45 Mn - -8,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8,000.00
Mar 31, 2026 -83,000.00
Sep 30, 2025 43,000.00
Jun 30, 2025 5,000.00
Mar 31, 2025 -16,000.00
Dec 31, 2024 -20,000.00
Sep 30, 2024 92,000.00
Jun 30, 2024 24,000.00
Mar 31, 2024 -80,000.00
Dec 31, 2023 134,000.00
Sep 30, 2023 119,000.00
Jun 30, 2023 -63,000.00
Mar 31, 2023 179,000.00
Dec 31, 2022 70,000.00
Sep 30, 2022 -304,000.00
Jun 30, 2022 -118,000.00
Mar 31, 2022 -5,000.00
API Access

Prime Medicine Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=PRME&period=max&api_key=YOUR_API_KEY